IIM
Ipswich Investment Management Portfolio holdings
AUM
$414M
This Quarter Return
+4.02%
1 Year Return
+15.04%
3 Year Return
+70.41%
5 Year Return
+132.95%
10 Year Return
+315.52%
AUM
$202M
AUM Growth
+$202M
(-3.8%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-5.86%
Top 10 Holdings %
Top 10 Hldgs %
29.36%
Holding
397
New
2
Increased
22
Reduced
64
Closed
263
Top Buys
| 1 |
Apple
AAPL
|
$5.44M |
| 2 |
Caterpillar
CAT
|
$1.03M |
| 3 |
Thermo Fisher Scientific
TMO
|
$963K |
| 4 |
Truist Financial
TFC
|
$742K |
| 5 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
$536K |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
$3.44M |
| 2 |
Nike
NKE
|
$967K |
| 3 |
Novartis
NVS
|
$470K |
| 4 |
Duke Energy
DUK
|
$470K |
| 5 |
Wells Fargo
WFC
|
$466K |
Sector Composition
| 1 | Healthcare | 18.78% |
| 2 | Energy | 15.68% |
| 3 | Industrials | 11.65% |
| 4 | Financials | 11.64% |
| 5 | Consumer Staples | 11.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Marriott International Class A Common Stock
MAR
$72.7B
| $2.71M | 1.34% | 40,828 +1,515 | +4% | +$101K |
|
27
Akamai
AKAM
$11.3B
| $2.69M | 1.33% | 48,042 -630 | -1% | -$35.2K |
|
|
28
Caterpillar
CAT
$196B
| $2.66M | 1.32% | 35,120 +13,587 | +63% | +$1.03M |
|
29
Merck
MRK
$210B
| $2.64M | 1.31% | 45,792 -554 | -1% | -$31.9K |
|
30
Colgate-Palmolive
CL
$67.9B
| $2.62M | 1.3% | 35,770 +101 | +0.3% | +$7.39K |
|
31
Church & Dwight Co
CHD
$22.7B
| $2.58M | 1.27% | 25,026 -480 | -2% | -$49.4K |
|
|
CELG
32
DELISTED
Celgene Corp
CELG
| $2.48M | 1.23% | 25,177 +315 | +1% | +$31.1K |
|
|
33
Duke Energy
DUK
$95.3B
| $2.44M | 1.21% | 28,408 -5,476 | -16% | -$470K |
|
34
Gilead Sciences
GILD
$140B
| $2.44M | 1.2% | 29,185 -1,356 | -4% | -$113K |
|
35
American International
AIG
$45.1B
| $2.43M | 1.2% | 45,930 -1,174 | -2% | -$62.1K |
|
36
TJX Companies
TJX
$152B
| $2.31M | 1.14% | 29,930 -146 | -0.5% | -$11.3K |
|
37
EOG Resources
EOG
$68.2B
| $2.27M | 1.12% | 27,166 -500 | -2% | -$41.7K |
|
38
Bristol-Myers Squibb
BMY
$96B
| $2.2M | 1.09% | 29,892 -1,620 | -5% | -$119K |
|
|
39
Novartis
NVS
$245B
| $2.15M | 1.06% | 26,058 -5,700 | -18% | -$470K |
|
40
AT&T
T
$209B
| $1.95M | 0.96% | 45,096 -1,000 | -2% | -$43.2K |
|
41
PepsiCo
PEP
$204B
| $1.79M | 0.88% | 16,862 -165 | -1% | -$17.5K |
|
42
Labcorp
LH
$23.1B
| $1.72M | 0.85% | 13,187 +1,325 | +11% | +$173K |
|
43
JPMorgan Chase
JPM
$829B
| $1.68M | 0.83% | 27,072 -321 | -1% | -$19.9K |
|
|
SIVB
44
DELISTED
SVB Financial Group
SIVB
| $1.66M | 0.82% | 17,460 +1,030 | +6% | +$98K |
|
45
T Rowe Price
TROW
$23.6B
| $1.6M | 0.79% | 21,864 -6,040 | -22% | -$441K |
|
46
Verizon
VZ
$186B
| $1.57M | 0.77% | 28,043 -1,175 | -4% | -$65.6K |
|
|
47
Nike
NKE
$114B
| $1.54M | 0.76% | 27,870 -17,520 | -39% | -$967K |
|
48
Coca-Cola
KO
$297B
| $1.53M | 0.75% | 33,646 | – | – |
|
|
49
Wells Fargo
WFC
$263B
| $1.52M | 0.75% | 32,201 -9,847 | -23% | -$466K |
|
50
TotalEnergies
TTE
$137B
| $1.29M | 0.64% | 26,764 -30 | -0.1% | -$1.44K |
|